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Abstract 
Background: Neuropathic pain that caused by lesion or dysfunction of the nervous system is associated with gene 
expression changes in the sensory pathway. Long noncoding RNAs (lncRNAs) have been reported to be able to regu‑
late gene expression. Identifying lncRNA expression patterns in the spinal cord under normal and neuropathic pain 
conditions is essential for understanding the genetic mechanisms behind the pathogenesis of neuropathic pain.
Results: Spinal nerve ligation (SNL) induced rapid and persistent pain hypersensitivity, characterized by mechanical 
allodynia and heat hyperalgesia. Meanwhile, astrocytes and microglia were dramatically activated in the ipsilateral 
spinal cord dorsal horn at 10 days after SNL. Further lncRNA microarray and mRNA microarray analysis showed that 
the expression profiles of lncRNA and mRNA between SNL and sham‑operated mice were greatly changed at 10 days. 
The 511 differentially expressed (>2 fold) lncRNAs (366 up‑regulated, 145 down‑regulated) and 493 mRNAs (363 up‑
regulated, 122 down‑regulated) were finally identified. The expression patterns of several lncRNAs and mRNAs were 
further confirmed by qPCR. Functional analysis of differentially expressed (DE) mRNAs showed that the most signifi‑
cant enriched biological processes of up‑regulated genes in SNL include immune response, defense response, and 
inflammation response, which are important pathogenic mechanisms underlying neuropathic pain. 35 DE lncRNAs 
have neighboring or overlapping DE mRNAs in genome, which is related to Toll‑like receptor signaling, cytokine–
cytokine receptor interaction, and peroxisome proliferator‑activated receptor signaling pathway.
Conclusion: Our findings uncovered the expression pattern of lncRNAs and mRNAs in the mice spinal cord under 
neuropathic pain condition. These lncRNAs and mRNAs may represent new therapeutic targets for the treatment of 
neuropathic pain.
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Background
Neuropathic pain is one of the most common chronic 
pain in humans and characterized by an increase in the 
responsiveness of nociceptive neurons in the peripheral 
and central nervous system (CNS) [1]. Peripheral and 
central sensitization represents the altered functional sta-
tus of nociceptive neurons and results from changes of a 
vast amount of functional protein and signaling pathways 
in the neuron and glial cell [2, 3]. Recent pharmaceutical 
research and discovery activities focus on well-charac-
terized molecular targets, such as ion channels, G-pro-
tein-coupled receptors, and kinases in neurons and glial 
cells localized along the nociceptive pathways, which are 
regarded as direct contributors to the sensitization of 
pain signaling systems [4, 5]. However, the transcriptional 
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or translational regulatory mechanisms underlying the 
expression and functional changes of these molecules are 
poorly defined.
RNAs that do not code for a protein (noncoding RNAs, 
ncRNAs) consist of two major classes: the small ncRNAs, 
which include microRNAs (miRNAs) and other noncod-
ing transcripts of less than 200 nucleotides, and long 
noncoding RNAs (lncRNAs), which are a novel class of 
non-protein coding transcripts longer than 200 nucleo-
tides [6]. LncRNAs were initially considered as transcrip-
tional by-products, but recent data suggest that lncRNAs 
can regulate gene expression via interfering with tran-
scription, post-transcriptional processing, chromatin 
remodeling, miRNA sequestration, and generating small 
ncRNAs [7, 8]. Also, lncRNAs are involved in various 
aspects of cell biology and disease etiology, such as devel-
opment [9], immune [10], cardiovascular disease [11], 
oncogenesis [12], and neurological disease [13]. LncR-
NAs are highly expressed in the CNS, and their expres-
sion profiles are associated with specific neuroanatomical 
regions, cell types, or subcellular compartments suggest-
ing their potential functional roles in the nervous sys-
tem [14–16]. It was reported that sciatic nerve resection 
induced differential expression of lncRNAs in dorsal root 
ganglia (DRG) [17]. Moreover, Zhao et  al. have recently 
identified a functional lncRNA Kcna2, which contributed 
to neuropathic pain by silencing Kcna2 in DRG neurons 
[18]. These findings indicate the involvement of lncRNAs 
in neuropathic pain.
The spinal cord is responsible for receiving input 
from nociceptors and projecting to the brain, and plays 
an important role in the integration and modulation of 
pain-related signals. To clarify the molecular mecha-
nisms underlying neuropathic pain and explore novel 
approaches for analgesic strategies, herein, we investi-
gated the genome-wide expression of lncRNAs in the spi-
nal cord following L5 spinal nerve ligation (SNL)-induced 
neuropathic pain. We found a large number of differen-
tially expressed (DE) lncRNAs and mRNAs in the spinal 
cord after SNL. Among them, 39 correlated lncRNA-
mRNA pairs, consisting of DE lncRNAs and mRNAs 
with adjacent or overlapping position relationship, were 
screened out. Our findings will provide new insights into 
the roles of lncRNAs in the regulation of neuropathic 
pain-associated genes.
Results
Model identification of neuropathic pain
The SNL model has been widely used in the investigation 
of the mechanisms underlying neuropathic pain [19]. 
Here we also found that SNL induced rapid (1 d) and per-
sistent (>21 d) mechanical allodynia (Figure 1a) and heat 
hyperalgesia (Figure 1b) in mice. We then harvested the 
spinal cord at 10 days (maintenance phase) after SNL and 
checked the expression of astrocytic marker GFAP and 
microglial marker IBA-1, which are known to be upregu-
lated in the spinal cord under neuropathic pain condition 
[20, 21]. As shown in Figure 1c, d, GFAP expression and 
IBA-1 expression were both increased in the ipsilateral 
dorsal horn in SNL animals but not in sham-treated ani-
mals, indicating that glial activation was induced in the 
spinal cord by SNL.
Overview of lncRNAs and mRNA expression profiles 
after SNL
We then detected the expression profiles of lncRNAs 
and mRNAs in the L5 spinal cord at 10  days after SNL 
by microarray. First, we obtained a graphically overview 
of the expression signatures of lncRNAs and mRNAs by 
using scatter plot and hierarchical clustering analyses. The 
scatter plots showed that a large number of lncRNAs and 
mRNAs were differentially expressed between SNL and 
sham-operated mice (Figure  2a, b). Hierarchical cluster 
analysis of all lncRNAs or mRNA showed that the 3 sham 
or 3 SNL samples were clustered together respectively, 
and signal intensity was consistent in sham or SNL group 
(Figure  2c, d). The heatmap of DE lncRNAs or mRNAs 
whose expression were up-regulated or down-regulated by 
twofold were magnified (Figure 2e, f ), indicating the high 
level of concordance in either SNL or sham samples. These 
data suggest that neuropathic pain is associated with the 
changes of lncRNAs and mRNAs in the spinal cord.
Differentially expressed lncRNAs and mRNAs
We further analyzed differentially expressed (DE) lncRNAs 
using significance analysis of microarrays method, follow-
ing the criteria q-value <0.05, and fold change >2. The 
results showed that 511 lncRNAs, containing 366 up-reg-
ulated and 145 down-regulated, were significantly changed 
in SNL group, comparing with the sham group. The most 
up-regulated lncRNAs were: uc009egw.1, Speer7-ps1, 
MM9LINCRNAEXON12113+, ENSMUST00000118074, 
and uc009nzx.1, of which uc009egw.1 showed the largest 
up-regulation (Log2 fold change = 7,332.4243). The most 
down-regulated lncRNAs were: AK045739, AK020832, 
AK047380, ENSMUST00000171761 and uc008dwx.1, of 
which AK045739 showed the largest down-regulation 
(Log2 fold change  =  −45.320816). Detailed information 
including the top 20 up-regulated and 20 down-regulated 
lncRNAs was listed in Table 1.
In the DE mRNAs, there are 493 genes whose mRNA 
change was more than twofold, and the number of up-
regulated (363) mRNAs was larger than down-regulated 
(122) mRNAs in SNL. These DE mRNAs contain many 
known genes involving in pain processing, including Cac-
na1g (calcium channel, voltage-dependent, T type, alpha 
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1G subunit, 16.0978 fold increase) [22], Trpv1 (transient 
receptor potential cation channel, subfamily V, member 
1, 9.31-fold increase) [23], Ccl5 (chemokine (C-C motif) 
ligand 5, 3.93-fold increase) [24], Cx3cr1 (chemokine 
(C-X3-C) receptor 1, 2.51-fold increase) [25], and Irf5 
(interferon regulatory factor 5) [26]. Besides, a lot of other 
genes, whose roles in pain have not been identified, were 
dramatically changed. Further analysis showed that 39 
genes whose expression were changed >tenfold, including 
38 up-regulated genes and 1 down-regulated gene, such as 
Sprr1a (small proline-rich protein 1A, 148.7-fold), Anxa10 
(annexin A10, 76.3-fold), and Kng1 (kininogen 1, 38.4-
fold); 66 genes whose expression was changed between 
5- and 10-fold, including 64 up-regulated and 2 down-
regulated genes. Detailed information about the top 20 
up-regulated and 20 down-regulated mRNAs was listed in 
Table 2.
Real‑time quantitative PCR (qPCR) validation of lncRNA 
and mRNA expression
To validate the reliability of the microarray results and 
also analyze the temporal changes of lncRNA and mRNA 
Figure 1 SNL induces persistent neuropathic pain and glial activation in the spinal cord. SNL‑induced rapid and persistent mechanical allodynia (a) 
and heat hyperalgesia (b). Data are expressed as mean ± SEM (n = 5 for each group). ***P < 0.001, two‑way repeated measures ANOVA. c, d Repre‑
sentative images of GFAP and IBA‑1 immunofluorescence in the L5 spinal cord from sham and SNL mice. GFAP and IBA‑1 immunoreactive were very 
low in sham‑treated mice, but significantly increased in the ipsilateral superficial dorsal horn at 10 days after SNL.
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Figure 2 SNL results in the expression profiling changes of lncRNA and mRNA. Scatter plot comparing global lncRNA (a) or mRNA (b) gene expres‑
sion profiles in the spinal cord between the SNL and sham mice. Green lines indicate twofold differences in either direction in lncRNA and mRNA 
expression. Heat map showing hierarchical clustering of overall lncRNAs (c) or mRNA (d) expression pattern of reliably measured probe sets. Heat 
map showing hierarchical clustering of LncRNAs (e) or mRNA (f), whose expression changes were more than twofold. In clustering analysis, up‑ and 
down‑regulated genes are colored in red and green, respectively.
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expression after SNL, the up-regulated lncRNAs includ-
ing Speer7-ps1 and uc007pbc.1, the down-regulated 
lncRNAs, including ENSMUST00000171761 and ENS-
MUST00000097503, the up-regulated mRNA Cyp2d9, 
and the down-regulated mRNA Mnx1 were randomly 
selected and analyzed by qPCR. The spinal cord tissues 
were collected from naïve animals, and SNL animals at 
1, 3, 10, and 21  days. Speer7-ps1 and uc007pbc.1, which 
are intergenic lncRNAs, were both significantly increased 
at 10  days and peaked at 21  days (Figure  3a, b). ENS-
MUST00000171761 and ENSMUST00000097503 are 
antisense overlap and bidirectional lncRNA with match-
ing gene Tagap (T-cell activation Rho GTPase-activating 
protein) and Zfp236 (zinc finger protein 236). They were 
significantly decreased at 10 days and persisted to 21 days 
(Figure  3c, d). Cyp2d9, a member of cytochrome P450, 
family 2, subfamily d, was increased more than 12-fold 
at 10 days (Figure 3e). Mnx1 is a sequence-specific DNA 
binding transcription factor. It decreased from 1 to 
21 days (Figure 3f ). In addition, the fold changes of these 
lncRNAs and mRNAs detected by qPCR at SNL 10 days 
were consistent with the results from microarray (Fig-
ure 3g), further supporting the reliability of the array data.
Class distribution of changed LncRNAs
lncRNAs were shown to regulate the expression of adja-
cent or overlapping mRNAs in genome [18, 27, 28]. 
Thus, the associations of DE lncRNAs with coding genes 
were analyzed and classified according to the method 
described by Li et  al. [29]. LncRNAs are classified into 
four groups: intergenic lncRNAs (lncRNAs are located 
and transcribed from intergenic regions, and do not 
overlap with known protein coding genes or other types 
of genes in genome. It is also called lincRNAs), antisense 
lncRNAs (LncRNA exon is transcribed from the anti-
sense strand and overlaps with a coding transcript exon), 
sense lncRNAs (LncRNA exon overlaps with a coding 
transcript exon on the same genomic strand), and bidi-
rectional lncRNAs (LncRNA is oriented head to head 
with a coding transcript within 1,000  bp). As shown in 
Figure  4, among the DE lncRNAs, intergenic lncRNAs 
were the largest category, with 236 up-regulated and 
90 down-regulated lncRNAs. The other DE lncRNAs 
included 100 antisense lncRNAs (78 up-regulated and 22 
down-regulated), 59 sense lncRNAs (37 up-regulated and 
22 down-regulated), and 26 bidirectional lncRNAs (15 
up-regulated and 11 down-regulated).
Functional prediction of DE mRNAs in SNL
To explore the molecular mechanism in neuropathic 
pain, we further did GO and pathway analysis of deregu-
lated genes in SNL versus sham. The GO results showed 
that the most significant enriched molecular function of 
up-regulated genes in SNL was chemokine activity, CCR 
Table 1 The detail information of the top 20 up-regulated and 20 down-regulated lncRNAs
Up‑regulated
lncRNAs




Log2 fold change  
(SNL/sham)
P‑value
uc009egw.1 7,332.4243 7.07E−08 AK045739 −45.320816 4.4E−09
Speer7-ps1 44.854053 3.44E−10 AK020832 −17.557217 4.08E−09
MM9LINCRNAEXON12113+ 28.60862 0.000138 AK047380 −13.752911 0.0000278
ENSMUST00000118074 27.38603 0.0000454 ENSMUST00000171761 −11.646089 7.18E−09
uc009nzx.1 26.05991 8.21E−06 uc008dwx.1 −10.924568 0.00000859
ENSMUST00000165428 25.460197 0.0000126 AK134918 −9.165875 0.02724757
CJ300890 23.606705 4.64E−06 ENSMUST00000160545 −8.490716 0.0000666
MM9LINCRNAEXON11661+ 20.514269 7.95E−08 AK013492 −8.088422 0.000000162
CJ059670 19.443495 1.31E−07 MM9LINCRNAEXON10414− −7.6248446 0.000158
NR_003548 18.795507 7.68E−08 CA874578 −6.9701576 0.017664054
AK086225 17.855263 0.0000016 AK045554 −6.809595 0.000000323
ENSMUST00000122927 15.532128 0.00000174 uc007cua.1 −6.378551 0.0000552
ENSMUST00000150343 14.018134 0.00000125 NR_030776 −5.654923 0.00000175
ENSMUST00000120145 13.556047 0.000000275 MM9LINCRNAEXON12090+ −4.920551 0.000137
MM9LINCRNAEXON10692+ 13.423789 0.00000243 MM9LINCRNAEXON10317+ −4.7705894 0.00000728
ENSMUST00000121611 13.380642 0.00000161 uc007kom.1 −4.603345 5.78E−09
humanlincRNA1606+ 13.149129 0.0000756 ENSMUST00000134042 −4.242255 0.0000337
AK085402 12.824574 0.000378 ENSMUST00000040306 −4.188862 0.00000142
ENSMUST00000121062 12.615327 0.000000185 AK157618 −4.0846663 0.000106
AK044525 12.42756 0.00000111 MM9LINCRNAEXON12066− −4.066157 0.00000917
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chemokine receptor binding, chemokine receptor bind-
ing, and cysteine-type endopeptidase inhibitor activ-
ity (Figure 5a). The most significant enriched biological 
processes of up-regulated genes in SNL were immune 
response, immune system process, defense response, 
and regulation of immune system process (Figure  5b). 
The most noteworthy enriched cellular components of 
up-regulated genes in SNL were extracellular region, 
extracellular space, extracellular region part, and exter-
nal side of plasma membrane (Figure 5c). The most sig-
nificant enriched molecular function of down-regulated 
genes in SNL were binding, receptor binding, calcium 
Table 2 The detail information of the top 20 up-regulated and 20 down-regulated mRNAs




 Sprr1a Small proline‑rich protein 1A 148.7115 1.84E−10
 Anxa10 Annexin A10 76.262054 1.61E−06
 4933402N22Rik RIKEN cDNA 4933402N22 gene 46.512726 1.62E−10
 Vmn2r101 Vomeronasal 2, receptor 101 44.090027 1.2E−08
 Kng1 Kininogen 1 38.42939 2.14E−08
 Olfr803 Olfactory receptor 803 31.403961 7.82E−08
 Gpr151 G protein‑coupled receptor 151 27.673513 5.95E−11
 LOC100048884 Novel member of the major urinary protein (Mup) gene family 24.719683 9.12E−09
 Mup11 Major urinary protein 11 24.027332 8.26E−10
 Mup7 Major urinary protein 7 23.950233 2.18E−08
 Mup12 Major urinary protein 12 23.768707 2.79E−10
 Mup13 Major urinary protein 13 23.234575 9.99E−08
 Mup19 Major urinary proteins 11 and 8 23.019644 0.000000314
 Mup8 Major urinary protein 8 22.686306 0.000000241
 Mup17 Major urinary protein 17 21.82689 8.07E−10
 Atf3 Activating transcription factor 3 19.8067 0.00000165
 Rreb1 Ras responsive element binding protein 1 19.512457 0.0000258
 Olfr648 Olfactory receptor 648 19.249556 0.00000434
 Clps Colipase, pancreatic 18.952599 0.000000801
 Vax2 Ventral anterior homeobox containing gene 2 17.30259 0.000187
Down‑regulated genes
 Lefty1 Left right determination factor 1 −10.109003 0.000000123
 Olfr866 Olfactory receptor 866 −7.406356 0.011693356
 Kcna5 Potassium voltage‑gated channel, shaker‑related subfamily, member 5 −5.9395947 0.0000537
 Tnnt2 Troponin T2, cardiac −4.8715253 0.000213
 Csprs Component of Sp100‑rs −4.639864 0.000183
 Gm5458 Predicted gene 5458 −3.9395294 0.000162
 Ypel4 Yippee‑like 4 (Drosophila) −3.8847303 0.0000976
 Sell Selectin, lymphocyte −3.7625916 0.000967
 Mnx1 Motor neuron and pancreas homeobox 1 −3.702038 0.003540842
 Fnip1 Folliculin interacting protein 1 −3.4727607 0.000226
 Epm2a Epilepsy, progressive myoclonic epilepsy, type 2 gene alpha −3.363634 0.00031
 H2-Ea-ps Histocompatibility 2, class II antigen E alpha, pseudogene −3.2939498 0.000021
 Chodl Chondrolectin −3.2821681 0.00000249
 Wtap Wilms’ tumour 1‑associating protein −3.1569881 0.0000001
 Pira4 Paired‑Ig‑like receptor A4 −3.1222947 0.03241746
 Eml4 Echinoderm microtubule associated protein like 4 −3.117333 0.020077666
 Tnnt2 Troponin T2, cardiac −3.0204759 0.0001
 Retnlg Resistin like gamma −2.9266624 0.000000051
 Mmp8 Matrix metallopeptidase 8 −2.9234846 0.000255
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ion binding, and tropomyosin binding (Figure  5d). The 
most significant enriched biological processes of down-
regulated genes in SNL were regulation of ATPase 
activity, monovalent inorganic cation transport, glu-
cosamine-containing compound catabolic process, and 
amino sugar catabolic process (Figure  5e). The most 
significant enriched cellular components of down-reg-
ulated genes in SNL were extracellular region, striated 
muscle thin filament, extracellular space, and cell part 
(Figure 5f ).
Similarly, different genes were analyzed in KEGG. The 
results showed that the up-regulated genes in SNL are 
involved in complement and coagulation cascades, Toll-
like receptor signaling pathway, chemokine signaling 
pathway, cytosolic DNA-sensing pathway, and cytokine–
cytokine receptor interaction, Changas disease, and 
Figure 3 QPCR validations of four deregulated lncRNAs and two deregulated mRNA in the spinal cord from SNL mice. The expressions of lncRNA 
Speer7‑ps1 (a), lncRNA Uc007pbc.1 (b), lncRNA ENSMUST00000171761 (c), and lncRNA ENSMUST00000097503 (d) were significantly deregulated at 
10 and 21 days after SNL. e The expression of Cyp2d9 mRNA was markedly up‑regulated at 10 days after SNL. f The expression of Mnx1 mRNA was 
significantly down‑regulated at 1, 3, 10 and 21 days after SNL. One‑way ANOVA followed by Tukey’s multiple comparison test. *P < 0.01, **P < 0.01, 
***P < 0.001. g Log 10 value of signal intensity detected by microarray.
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NOD-like receptor signaling pathway (Figure 6a). Down-
regulated genes in SNL are involved in amyotrophic 
lateral sclerosis (ALS), prostate cancer, citrate cycle, glu-
tamatergic synapse, osteoclast differentiation and NOD-
like receptor signaling pathway (Figure 6b).
Comparison of our DE mRNAs with previously published 
microarrays
Previous studies have shown differential gene expression 
profile in the spinal cord in rats with neuropathic pain 
[30, 31]. In order to compare neuropathic pain-associ-
ated gene expression patterns in mice and rats, we did the 
overlap analysis between other’s microarray data from rat 
[30] and our current data from mice (Figure 7a). LaCroix-
Fralish et al. reported that 88 genes were upregulated and 
83 genes were downregulated in the spinal cord 7  days 
after L5 nerve root ligation in rats [30]. Surprisingly, 
compared to 361 up-regulated genes and 119 down-reg-
ulated genes in mouse, only 1 gene (Cd74) was upregu-
lated and 2 genes (Nefm, Aco2) were downregulated in 
both rats and mice (Figure 7b). In addition, we compared 
our array data with 79 significantly regulated genes which 
were identified by meta-analysis from 20 independent 
microarray experiments from rats and mice after tissue 
inflammation or nerve injury [2]. We observed an over-
lap of 15 genes with the meta-analysis dataset (Figure 7c). 
These genes included 14 up-regulated genes (Ctss, C1qb, 
C1qc, Npy, Cd74, Gal, Aif1, Calca, Cxcl10, Atf3, Ccl2, 
Ctsh, Fcgr2b and Sprr1a) and 1 down-regulated gene 
(Nefm) (Figure 7d).
Relational analysis of lncRNAs and mRNAs
As some lncRNAs have been suggested to play key roles 
in regulating the expression of their neighboring or over-
lapping genes in genome wide, we further screened out 
DE mRNAs related to DE lncRNAs based on their loca-
tion distributions on mouse chromosomes by UCSC 
Genome Browser. In the spinal cord, there are 39 DE 
lncRNA-mRNA pairs for 35 DE lncRNAs and 35 DE 
mRNAs. Among them, 32 pairs exhibited coordinated 
expression changes, and 7 pairs were non-coordinated, 
which may suggest a complex and various regulatory 
mechanisms across different lncRNAs and their tar-
get mRNAs. Intriguingly, all the seven non-coordinated 
lncRNA-mRNA pairs belong to intergenic lncRNA-
mRNA pairs (Table  3). Further GO and pathway analy-
sis showed that the high enriched molecular functions 
include pheromone binding, chemokine activity, high-
density lipoprotein binding, and phosphatidylcholine-
sterol O-acyltransferase activator activity (Figure  8a). 
Based on gene-pathway network graph analysis, we 
found that the DE mRNAs from lncRNA-mRNA pairs, 
such as Cxcl9 (chemokine (C-X-C motif ) ligand 9), 
Cxcl10 (chemokine (C-X-C motif ) ligand 10), Cxcl11 
(chemokine (C-X-C motif ) ligand 11), Trhr (thyrotropin 
releasing hormone receptor), and Apoa2 (apolipopro-
tein A-II), might involve in toll-like receptor signaling 
pathway, calcium signaling pathway, and PPAR signaling 
pathway (Figure 8b; Table 3), which have been proven to 
be involved in neuropathic pain pathogenesis [32–34].
Discussion
Chronic neuropathic pain is a somatosensory disorder 
caused by nerve injury or disease that affects the nerv-
ous system [35]. Evidence suggested that the particu-
lar patterns of gene expression at different levels of the 
nociceptive system play important roles in the develop-
ment and maintenance of neuropathic pain [2, 36]. Over 
the past decades, the molecular mechanisms underlying 
neuropathic pain have been extensively studied; how-
ever, the pathophysiological process of pain is still vague. 
LncRNAs were recently shown to regulate gene expres-
sion [37] and traffic cellular protein complexes, genes, 
and chromosomes to appropriate locations [8]. Their 
function in regulating gene expression switching in the 
maintenance phase of neuropathic pain is poorly under-
stood. In this study, we for the first time identified the 
global expression changes in lncRNAs and analyzed their 
characteristics and possible relation with coding genes 
in the spinal cord under neuropathic pain condition. 
The 24,833 lncRNAs were detected in the spinal cord 
of mice. Among them, 366 lncRNAs were up-regulated 
and 145 lncRNAs were down-regulated at 10  days after 
SNL. These DE lncRNAs are consistently altered in a high 
Figure 4 Distribution of various types of DE lncRNAs. Four classes 
(sense overlap lncRNAs, antisense overlap lncRNAs, bidirectional 
lncRNAs and intergenic lncRNAs) were analyzed.
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percentage of analyzed spinal cords from SNL and sham 
mice, suggesting that lncRNAs may be involved in neu-
ropathic pain processing. So far, most DE lncRNAs have 
not been functionally characterized. Although it was still 
too early to translate this knowledge into the develop-
ment of novel analgesic agents for better pain relief, these 
findings may likely provide novel insight into the molecu-
lar basis of pain.
In this study, the expression profiles of mouse genome-
wide mRNAs were also detected using lncRNA Micro-
array Chip at the same time. Among DE mRNAs, the 
up-regulated mRNAs are far more numerous than the 
down-regulated in SNL samples, which reflects the emer-
gence of new biology processes and pathways in patho-
logical conditions. A number of reported pain-related 
genes, including Cacna1g, Trpv1, Ccl5, Cx3cr1 and Irf5 
were dramatically increased after SNL. Moreover, a lot of 
other mRNAs, such as Sprr1a, Anxa10, Kng1, and Gpr151 
(G-protein-coupled receptor 151), whose functions are 
unclear in the spinal cord were also screened out. As 
the expression changes for some genes may be related to 
nerve damage and homeostatic responses to denervation, 
further studies are needed to identify whether they are 
involved in neuropathic pain processing.
Figure 5 Biological functions of differentially expressed mRNAs with fold changes >2. a–c The significant molecular function, biological process 
and cellular component of up‑regulated mRNAs. d–f The significant molecular function, biological process and cellular component of down‑regu‑
lated mRNAs.
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Figure 6 Pathway analysis for 366 up‑regulated and 127 down‑regulated mRNAs with fold changes >2. a The significant pathways for up‑regulated 
genes in SNL group. b The significant pathways for down‑regulated genes in SNL group.
Figure 7 Gene overlap analysis between the present data and previously published microarrays in pain model. a Venn diagram showing the 
number of common up‑ and down‑regulated genes in our present mice model (mice‑up, mice‑down) and previously published rat model (rat‑up, 
rat‑down) after SNL. Only three genes were shared with the same tendency between the two microarray experiments. b The detailed information 
of the overlap genes that were significantly regulated in both the mice and rat spinal cord. c Venn diagram showing the overlap between gene‑sets 
of our present data and previously published microarrays (Up-P up‑regulated genes of the previous studies, Down-P down‑regulated genes of the 
previous studies, Up-A up‑regulated genes of the author’s data, Down-A down‑regulated genes of the author’s data). d The detailed information of 
14 up‑regulated and 1 down‑regulated overlapped genes between our present data and previously published microarrays.
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Table 3 DE lncRNAs and their neighboring or overlapping DE mRNAs
LncRNAs Relationship mRNAs Function prediction of DE lncRNAs 
with related mRNAs
Sequence name Fold change Regulation GeneSymbol Fold change Regulation Molecular Func‑
tion
Pathway
ENSMUST00000160110 3.9130898 Down Antisense 
overlap
Phtf1 2.1720073 Down GO:0003677 DNA 
binding
AK136749 2.089502 Up Antisense 
overlap
Asap2 8.8652115 Up
ENSMUST00000121460 11.624642 Up Antisense 
overlap




mouselincRNA1303+ 2.959626 Up Intergenic Vmn1r54 2.5373068 Up
MM9LINCR-
NAEXON12110+





































C75950 2.3177905 Up Intergenic Gm5136 2.2296717 Down












20.514269 Up Intergenic Asap2 8.8652115 Up
humanlincRNA1070+ 6.5686955 Up Intergenic Vax2 17.30259 Up GO:0003700 tran‑
scription factor 
activity
humanlincRNA2255− 6.4199057 Up Intergenic Trhr 2.1457152 Down
mouselincRNA1631+ 2.131738 Up Intergenic Klhl15 2.0060081 Up GO:0005515 protein 
binding
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Table 3 continued
LncRNAs Relationship mRNAs Function prediction of DE lncRNAs 
with related mRNAs
Sequence name Fold change Regulation GeneSymbol Fold change Regulation Molecular Func‑
tion
Pathway



























3.7596319 Up Intergenic Zfp654 2.1100945 Down GO:0003677 DNA 
binding
GO:0008270 zinc ion 
binding



































uc008iab.1 2.1543121 Down Intergenic Fam160b1 2.5731633 Up
MM9LINCR-
NAEXON12066−

























AK054438 2.3012707 Up Intergenic Ifi202b 9.431554 Up GO:0005515 protein 
binding
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Based on the GO term enrichment analyses of DE 
mRNA, we found that significantly enriched molecu-
lar functions and biological processes of up-regulated 
gene in SNL vs sham were mainly involved in chemokine 
activity, inflammation, and immunity. These findings 
are consistent with previous studies showing that neu-
roinflammation, manifested as infiltration of immune 
cells [38], activation of glial cells [39] and production of 
inflammatory mediators [40] in the peripheral and CNS, 
plays an important role in the induction and maintenance 
of chronic pain [41]. Additionally, our immunostaining 
of GFAP and IBA-1 showed dramatic glial activation in 
the spinal cord at 10  days after SNL. From significant 
pathway analyses of DE gene, the third most significant 
enriched pathway of the up-regulated genes in SNL vs 
sham is the toll-like receptor signaling pathway. Indeed, 
Tlr2 [42], Tlr4 [43], and Tlr7 [44] have been implicated 
as potential therapeutic targets in neuropathic and other 
pain models. The data collectively indicate that anti-neu-
roinflammation may be an effective strategy for the treat-
ment of neuropathic pain.
Previous studies utilizing cDNA microarrays to analyze 
gene expression profiles primarily focus on pain models 
in rats, rarely in mice [2]. The overlap analysis showed 
little overlap between rat and mice spinal cord gene 
expression patterns under neuropathic pain states, sug-
gesting the species difference in gene expression. How-
ever, we found that there were 15 overlap genes between 
our current data and meta-analysis results reported by 
LaCroix-Fralish et al. [2]. These overlap genes including 
Atf3, Sprr1al and Nefm can be induced by nerve damage, 
which contribute to chronic pain [45–47]. In addition, 
gene ontology-based functional annotation clustering 
analyses of the previous gene chip study revealed strong 
evidence for regulation of immune-related genes in pain 
states, which was consistent with our data.
Although lncRNAs play important roles in the regula-
tion of gene expression [48], there is a large gap between 
the number of existing lncRNAs and their known asso-
ciation with a particular molecular or cellular function 
[49]. Regulatory mechanisms and major functional prin-
ciples of lncRNAs are complex and quite obscure. Unlike 
Table 3 continued
LncRNAs Relationship mRNAs Function prediction of DE lncRNAs 
with related mRNAs










2.4868224 Down Intergenic Ppp2r5c 2.1656942 Down GO:0008601 protein 
phosphatase 
type 2A regulator 
activity







2.5727692 Down Intergenic Cd68 2.6843183 Up
MM9LINCR-
NAEXON11793+
2.671865 Up Intergenic Cd68 2.6843183 Up
ENSMUST00000120184 2.5531633 Down Sense overlap Amy2b 2.4439986 Down











uc009pmr.1 3.20246 Down Sense overlap Elmod1 2.2530112 Down
uc007cua.1 6.378551 Down Sense overlap Tnnt2 3.0204759 Down
ENSMUST00000040306 4.188862 Down Sense overlap H2-Ea-ps 3.2939498 Down
uc008uzw.1 2.2820547 Up Sense overlap Laptm5 2.1142242 Up
ENSMUST00000117412 2.5116289 Up Sense overlap Gm10147 2.2881203 Up
ENSMUST00000119882 3.1487308 Up Sense overlap Gm10486 2.4736855 Up
ENSMUST00000119882 3.1487308 Up Sense overlap Gm14819 3.018787 Up
uc008tbm.1 10.098583 Up Sense overlap Mup17 21.82689 Up
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microRNA, there are no common languages that can be 
used to predict lncRNAs’ target genes and function by 
their sequence information or secondary structure. Accu-
mulating evidence suggests that a number of lncRNAs 
function locally to activate or repress their neighboring 
or overlapping genes’ expression [18, 27, 50]. In this 
study, we found that intergenic lncRNAs (lincRNAs) were 
the largest category in all DE lncRNAs after SNL. In real-
ity, lincRNAs are found to be conserved across multiple 
vertebrate species [51] and perform important functions 
Figure 8 Function prediction of DE lncRNAs with related mRNAs. a Molecular function enrichment analysis of DE lncRNAs‑related mRNAs. The 
enrichment scores (−log10 (P‑value)) of the GO molecular function were shown in the histogram. b Gene‑pathway network graph of DE lncRNAs‑
related mRNAs from Table 3. The DE lncRNAs‑related genes and the corresponding pathways were shown in the circles and boxes, respectively. The 
color of pathway terms is defined by the enrichment P value.
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in many cellular processes, from cell proliferation to can-
cer progression [52]. Furthermore, lincRNAs can func-
tion through different types of mechanisms, including 
cis or trans transcriptional regulation, translational con-
trol, splicing regulation, and other post-transcriptional 
regulation [33]. We examined whether their neighbor-
ing or overlapping protein-coding genes in the genome 
are simultaneously DE in the spinal cord after SNL, and 
found that there are 39 DE lncRNA-mRNA pairs. Our 
further analysis showed that an up-regulated lincRNA, 
MM9LINCRNAEXON10576− in the spinal cord after 
SNL was found to be located near Cxcl10, Cxcl9 and 
Cxcl11 gene cluster in mice chromosome 5. All the four 
RNAs have the same expression trends and increased 
more than twofold after SNL. Recently, studies using ani-
mal models have shown that upregulation of chemokines 
in the spinal cord play a vital role in the development and 
maintenance of chronic pain [41, 53, 54]. Indeed, recent 
research found that Cxcl10 and its receptor Cxcr3 were 
involved in inflammatory pain and cancer pain [55–57]. 
Therefore, lncRNA MM9LINCRNAEXON10576− may 
contribute to neuropathic pain through regulation of 
chemokines Cxcl10, Cxcl9 and Cxcl11.
In our microarray results, 12 DE mRNA have their cor-
responding DE sense-overlap lncRNAs, and the change 
patterns of these lncRNA were same as that of their 
accompanying protein-coding genes. Di et  al. found 
that a sense-overlap lncRNA arising from the CCAAT/
enhancer-binding protein alpha (Cebpa) gene locus can 
bind to DNA methyltransferase 1 (DNMT1) and pre-
vent Cebpa gene locus methylation, then to increase the 
expression of Cebpa gene. Their deep sequencing of tran-
scripts associated with DNMT1 combined with genome-
scale methylation and expression profiling extend the 
generality of this finding to numerous gene loci. [27]. 
Given that the 12 DE mRNA and their DE sense-overlap 
lncRNAs were both increased after SNL, it’s possible that 
the DE sense-overlap lncRNAs regulate the expression of 
their sense-overlapping mRNAs via demethylation after 
SNL.
Conclusion
Our results demonstrated that lncRNA transcripts were 
highly enriched and hundreds of lncRNAs were differ-
entially expressed in the spinal cord after SNL. Dozens 
of DE lncRNAs were observed to have neighboring or 
overlapping DE mRNAs in genome. These lncRNAs may 
locally regulate their related protein-genes expression 
and play key roles in the pathogenesis of neuropathic 
pain. Further studies are required to clarify the molecu-
lar and cellular functions of DE lncRNAs and determine 




Adult male ICR mice (male, 8  weeks) were maintained 
on a 12:12 light–dark cycle at a room temperature of 
22 ± 1°C with free access to food and water. The experi-
mental procedures were approved by the Animal Care 
and Use Committee of Nantong University and per-
formed in accordance with the guidelines of the Inter-
national Association for the Study of Pain. To produce a 
SNL, animals were anesthetized with isoflurane and the 
L6 transverse process was removed to expose the L4 and 
L5 spinal nerves. The L5 spinal nerve was then isolated 
and tightly ligated with 6-0 silk threads [58]. For sham 
operations, the L5 spinal nerve was exposed but not 
ligated.
Behavioral test
Animals were habituated to the testing environment daily 
for at least 2 days before baseline testing. The room tem-
perature remained stable for all experiments. For testing 
mechanical sensitivity, animals were put in boxes on an 
elevated metal mesh floor and allowed 30 min for habitu-
ation before examination. The plantar surface of each 
hindpaw was stimulated with a series of von Frey hairs 
with logarithmically incrementing stiffness (0.02–2.56 g, 
Stoelting, Wood Dale, IL, USA), presented perpendicular 
to the plantar surface (2–3 s for each hair). The 50% paw 
withdrawal threshold was determined using Dixon’s up-
down method [59]. For testing heat sensitivity, animals 
were put in plastic boxes and allowed 30 min for habitu-
ation. Heat sensitivity was tested by radiant heat using 
Hargreaves apparatus (IITC Life Science Inc., Woodland 
Hills, CA, USA) and expressed as paw withdrawal latency 
(PWL). The radiant heat intensity was adjusted so that 
basal PWL is between 10 and 14 s, with a cutoff of 18 s to 
prevent tissue damage.
Immunohistochemistry
At 10  days after SNL or sham-operation, animals were 
deeply anesthetized with isoflurane and perfused through 
the ascending aorta with PBS followed by 4% paraformal-
dehyde with 1.5% picric acid in 0.16 M PB. After the per-
fusion, the L4–L5 spinal cord segments were removed 
and postfixed in the same fixative overnight. Spinal cord 
sections (30 μm, free-floating) were cut in a cryostat. The 
sections were first blocked with 5% goat serum for 2 h at 
room temperature. The sections were then incubated 
overnight at 4°C with the following primary antibodies: 
GFAP antibody (mouse, 1:6,000; Millipore, Billerica, MA, 
USA), IBA-1 antibody (Mouse, 1:3,000, Serotec, Kidling-
ton, UK). The sections were then incubated for 2 h at room 
temperature with FITC-conjugated secondary antibodies 
(1:1,000, Jackson ImmunoResearch). The stained sections 
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were examined with a Leica fluorescence microscope, and 
images were captured with a CCD Spot camera.
Tissue collection and RNA isolation
We prepared nine mice for SNL and nine mice for sham-
operation. At 10  days after operation, the animals were 
deeply anesthetized with isoflurane and perfused through 
the ascending aorta with saline. After the perfusion, the 
L4–L5 spinal cord segments were collected. Total RNA 
was extracted from the spinal cord dorsal horn tissue 
using Trizol reagent (Invitrogen, Carlsbad) according to 
the manufacturer’s protocol. The RNA concentration and 
purity were assayed by the absorbance values at 260 and 
280  nm using the NanoDrop 1000 Spectrophotometer 
(Thermo). RNA integrity was checked by electrophore-
sis on 2% (m/v) agarose gels. After these testing, equal 
mRNA from three mice under the same treatment was 
mixed as one sample. Therefore, six samples (3 for SNL 
and 3 for sham) were sent for microarray analysis.
Microarray assay
The gene chip of the mouse lncRNA microarray V2.0 
(8  ×  60K, Arraystar), which includes 25,376 lncRNA 
probes and 31,423 coding gene probes, was used in the 
experiments. The total RNAs of sham and SNL groups 
were individually hybridized with gene chips. Briefly, 
RNA was purified from 1 μg total RNA after removing 
rRNA. The RNA sample was then transcribed into fluo-
rescent cRNA along the entire length of the transcripts 
without 3′ bias utilizing random primers. The labeled 
cRNAs were hybridized to mouse lncRNA microarray. 
Finally, arrays were scanned by Agilent Scanner G2505B. 
The array images were analyzed by Agilent Feature 
Extraction software (version 10.7.3.1). The GeneSpring 
GX v11.5.1 software package (Agilent Technologies) was 
utilized to analyze quintile normalization and subsequent 
data processing. The microarray hybridization was car-
ried out by Kangchen Bio-tech, Shanghai, China.
Bioinformatics analysis
Differentially expressed lncRNAs and mRNAs with sta-
tistical significance were identified through Volcano Plot 
filtering. The threshold used to screen up- or down-reg-
ulated RNAs was fold-change >2.0 (P < 0.05). Hierarchi-
cal clustering was carried out by Cluster 3.0, and the heat 
maps were generated in Java Treeview. The DE mRNAs 
which were adjacent to or overlap with the DE lncRNAs 
were recognized as DE lncRNAs related mRNAs using 
UCSC Genome Browser. The differentially expressed 
mRNAs or DE lncRNAs related mRNAs were analyzed 
by pathway annotation and gene ontology (GO) func-
tional enrichment using CapitalBio® Molecule Annota-
tion System V3.0 (MAS3.0). The −log10 (P-value) of the 
GO and pathway results were shown in the histogram.
Real‑time reverse transcription‑polymerase chain reaction 
(RT‑PCR)
The microarray results were confirmed by RT-PCR. 
Total RNA was extracted from the spinal cord tissue 
as described above and total RNA was reverse tran-
scribed using random hexamers primer (TaKaRa Bio 
Inc) according to the manufacturer’s description. The 
expression level of six genes was checked, including 
Speer7-ps1, uc007pbc.1, ENSMUST00000171761, ENS-
MUST00000097503, Cyp2d9, and Mnx1. The Gapdh was 
used as house-keeping gene. The sequences of all prim-
ers were shown in Table 4. RT-PCR was performed using 
the Fast Start Universal SYBR Green Master (TaKaRa Bio 
Table 4 Primer sequences used in Real-Time PCR
Sequence name Primer sequence Amplicon size (bp)
Speer7-ps1 F: 5′‑CATGCTCTCATGCTCACCGA‑3′ 70
R: 5′‑TACGCTGTAGGACCAGAACAC‑3′
uc007pbc.1 F: 5′‑CATCTAGACCCGTAACGCCC‑3′ 340
R: 5′‑TGGTAGGCAAGCATCCACAG‑3′
ENSMUST00000171761 F: 5’‑TCGGAGACTTCTCTTCCGGT ‑3’ 108
R: 5′‑AAGACAATGCAGATGGGGCA‑3′
ENSMUST00000097503 F: 5′‑AGGTCATCCCACTTTGGTACAC‑3′ 77
R: 5′‑GAGTTTGGTTTGCGGGGTCT‑3′
Cyp2d9 F: 5′‑TGTCTACCCTGCGCAACTTT‑3′ 71
F: 5′‑GTGATTGGCCTCCTTGGTCA‑3′
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Inc) with 20-μl reaction system, according to the manu-
facturer’s protocol, in a Rotor-Gene 6000 instrument 
(Hamburg, Germany). The melting-curve analysis was 
performed in order to monitor the specificity of produc-
tion. All experiments were replicated three times. The 
gene expression levels in the sham and SNL groups were 
analyzed with the 2−∆∆CT method.
Statistical analysis
The behavioral data were analyzed by two-way analy-
sis of variance. The RT-PCR results were reported as 
mean  ±  SEM and analyzed by the one-way analysis of 
variance followed by Tukey’s multiple comparison test. 
The criterion for statistical significance was P < 0.05.
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